حدد سهمًا أو عملة مشفرة في شريط البحث للحصول على ملخص
Eiken Chemical Co Ltd
4549Eiken Chemical Co., Ltd. engages in the manufacturing and sale of clinical diagnostics in Japan. It offers microbiological reagents for diagnosis of microorganism infection, such as mediums, antimicrobial susceptibility, and rapid test reagents; urinalysis test strips for occult blood, protein, and glucose; and fecal immunochemical tests reagents for screening of colorectal cancer. The company also provides immunological and serological reagents to detect and monitor infectious disease, rheumatism, inflammation, atrophic gastritis, and prostate specific antigens; and clinical chemistry tests to measure and analyze biological components in blood serum and urine. In addition, it sells reagents and devices of microbiological test for food poisoning bacteria and environmental inspection; and offers nucleic acid amplification method, as well as provides various types of automated analyzers. The company was formerly known as Nihon Eiyokagaku Co., Ltd. and changed its name to Eiken Chemical Co., Ltd. in 1969. Eiken Chemical Co., Ltd. was incorporated in 1939 and is headquartered in Tokyo, Japan. Address: 4-19-9 Taito, Tokyo, Japan, 110-8408
Analytics
سعر الهدف في وول ستريت
341 838.48 JPYنسبة السعر إلى الأرباح
33.5428العائد الربحي
2.54 %السنة الحالية
العام الماضي
الربع الحالي
الربع الأخير
السنة الحالية
العام الماضي
الربع الحالي
الربع الأخير
الشخصيات الرئيسية 4549
تحليلات الأرباح 4549
نمو الأرباح على مدى 5 سنوات
37 %النمو المستمر
1 سنةمعدل الدفع 5 سنوات في المتوسط
31 %تاريخ الأرباح 4549
تقييم الأسهم 4549
المالية 4549
نتائج | 2019 | ديناميات |